Therapeutic inertia in relapsing-remitting multiple sclerosis

被引：0

作者：

Rodrigues, R. ^{[1
]}

Rocha, R. ^{[2
]}

Bonifacio, G. ^{[3
]}

Ferro, D. ^{[4
]}

Sabenca, F. ^{[5
]}

Goncalves, A. I. ^{[6
]}

Correia, F. ^{[2
]}

Pinheiro, J. ^{[5
]}

Loureiro, J. L. ^{[1
]}

Guerreiro, R. P. ^{[3
]}

Vale, J. ^{[6
]}

Sa, M. J. ^{[4
]}

Costa, A. ^{[4
]}

机构：

[1] Ctr Hosp Entre Douro & Vouga, Santa Maria Feira, Portugal

[2] Hosp Pedro Hispano, Unidade Local Saude Matosinhos, Matosinhos, Portugal

[3] Ctr Hosp Setubal, Setubal, Portugal

[4] Ctr Hosp Univ Sao Joao, Porto, Portugal

[5] Ctr Hosp Vila Nova de Gaia Espinho, Vila Nova De Gaia, Portugal

[6] Hosp Beatriz Angelo, Loures, Portugal

来源：

MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P0925

引用

页码：557 / 558

页数：2

共 50 条

[31] Resistance Training in Relapsing-Remitting Multiple Sclerosis
Dalgas, U.
Kant, M.
Stenager, E.
AKTUELLE NEUROLOGIE, 2010, 37 (05) : 213 - 218
[32] An update on cladribine for relapsing-remitting multiple sclerosis
Holmoy, Trygve
Torkildsen, Oivind
Myhr, Kjell-Morten
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (15) : 1627 - 1635
[33] Daclizumab for the treatment of relapsing-remitting multiple sclerosis
Herwerth, Marina
Hemmer, Bernhard
EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (06) : 747 - 753
[34] A CASE OF RELAPSING-REMITTING TUMEFACTIVE MULTIPLE SCLEROSIS
Turnbull, H.
Karsan, N.
Hogg, F.
Pereira, A.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2012, 83
[35] Alemtuzumab in the treatment of relapsing-remitting multiple sclerosis
Fox, Edward J.
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (12) : 1789 - 1797
[36] Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis
Hersh, Carrie M.
Cohen, Jeffrey A.
IMMUNOTHERAPY, 2014, 6 (03) : 249 - 259
[37] Natalizumab in spinal relapsing-remitting multiple sclerosis
Zecca, C.
Kamm, C.
Riccitelli, G. C.
Heldner, M.
Caporro, M.
Gobbi, C.
EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 457 - 457
[38] Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
Menge, Til
Dubey, Divyanshu
Warnke, Clemens
Hartung, Hans-Peter
Stuve, Olaf
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (10) : 1131 - 1139
[39] Development of laquinimod for relapsing-remitting multiple sclerosis
Jeffery, Douglas R.
FUTURE NEUROLOGY, 2008, 3 (06) : 641 - 648
[40] Oral fingolimod for relapsing-remitting multiple sclerosis
Doggrell, Sheila A.
EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (10) : 1777 - 1781

← 1 2 3 4 5 →